Healthcare provider profile · identity verified

Tamara Montgomery, D.O.

Family Practice · MARIETTA, OH · NPI 1114995602

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	77
Levothyroxine Sodium	Levothyroxine Sodium	620	65
Sertraline Hcl	Sertraline Hcl	504	44
Furosemide	Furosemide	421	49
Potassium Chloride	Potassium Chloride	335	44
Eliquis	Apixaban	325	39
Amlodipine Besylate	Amlodipine Besylate	317	53
Metoprolol Succinate	Metoprolol Succinate	309	39
Gabapentin	Gabapentin	281	23
Buspirone Hcl	Buspirone Hcl	232	29
Metoprolol Tartrate	Metoprolol Tartrate	226	38
Lisinopril	Lisinopril	222	38
Pantoprazole Sodium	Pantoprazole Sodium	222	38
Omeprazole	Omeprazole	217	41
Tamsulosin Hcl	Tamsulosin Hcl	215	22
Donepezil Hcl	Donepezil Hcl	210	22
Losartan Potassium	Losartan Potassium	183	31
Clopidogrel	Clopidogrel Bisulfate	158	22
Metformin Hcl	Metformin Hcl	152	23
Allopurinol	Allopurinol	134	14
Divalproex Sodium	Divalproex Sodium	128	11
Mirtazapine	Mirtazapine	128	14
Prednisone	Prednisone	123	40
Trazodone Hcl	Trazodone Hcl	116	15
Famotidine	Famotidine	114	18
Finasteride	Finasteride	113	11
Duloxetine Hcl	Duloxetine Hcl	111	13
Montelukast Sodium	Montelukast Sodium	100	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	suppressed
Lorazepam	Lorazepam	80	17
Escitalopram Oxalate	Escitalopram Oxalate	79	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	15
Memantine Hcl	Memantine Hcl	79	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	76	16
Amiodarone Hcl	Amiodarone Hcl	75	suppressed
Spironolactone	Spironolactone	75	11
Carvedilol	Carvedilol	74	13
Ondansetron Hcl	Ondansetron Hcl	74	22
Hydralazine Hcl	Hydralazine Hcl	70	suppressed
Jardiance	Empagliflozin	70	suppressed
Levetiracetam	Levetiracetam	70	suppressed
Cephalexin	Cephalexin	69	21
Xarelto	Rivaroxaban	68	suppressed
Meloxicam	Meloxicam	66	11
Carbidopa-Levodopa	Carbidopa/Levodopa	63	suppressed
Pravastatin Sodium	Pravastatin Sodium	63	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	60	suppressed
Citalopram Hbr	Citalopram Hydrobromide	59	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	12
Lamotrigine	Lamotrigine	57	suppressed
Baclofen	Baclofen	55	suppressed
Risperidone	Risperidone	53	suppressed
Benztropine Mesylate	Benztropine Mesylate	52	suppressed
Torsemide	Torsemide	51	suppressed
Tizanidine Hcl	Tizanidine Hcl	49	suppressed
Diltiazem Hcl	Diltiazem Hcl	48	suppressed
Carbamazepine	Carbamazepine	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Atenolol	Atenolol	45	suppressed
Clonazepam	Clonazepam	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	14
Januvia	Sitagliptin Phosphate	44	suppressed
Bumetanide	Bumetanide	43	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	15
Sucralfate	Sucralfate	42	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Bupropion Hcl Sr	Bupropion Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	11
Memantine Hcl Er	Memantine Hcl	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Glipizide	Glipizide	34	suppressed
Labetalol Hcl	Labetalol Hcl	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	16
Alendronate Sodium	Alendronate Sodium	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Ozempic	Semaglutide	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	19
Warfarin Sodium	Warfarin Sodium	29	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Vascepa	Icosapent Ethyl	27	suppressed
Albuterol Sulfate	Albuterol Sulfate	26	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	25	25
Clozapine	Clozapine	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Enulose	Lactulose	25	suppressed
Methenamine Hippurate	Methenamine Hippurate	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Constulose	Lactulose	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Azithromycin	Azithromycin	21	13
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Colestipol Hcl	Colestipol Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Topiramate	Topiramate	19	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Novolog	Insulin Aspart	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	16	16
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Xifaxan	Rifaximin	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Nystatin	Nystatin	15	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	12
Tradjenta	Linagliptin	14	suppressed
Acetic Acid	Acetic Acid	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Risperdal Consta	Risperidone Microspheres	13	suppressed
Acarbose	Acarbose	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error